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Edited by Vladimir SkulachevAbstract The hypoxia-inducible factor (HIF) transcriptional
system enables cell adaptation to limited O2 availability, trans-
ducing this signal into patho-physiological responses such as
angiogenesis, erythropoiesis, vasomotor control, and altered en-
ergy metabolism, as well as cell survival decisions. However,
other factors beyond hypoxia are known to activate this pleiotro-
pic transcription factor. The aim of this study was to character-
ize HIF in human hematopoietic stem cells (HSCs) and evidence
is provided that granulocyte colony stimulating factor-mobilized
CD34+- and CD133+-HSCs express a stabilized cytoplasmic
form of HIF-1a under normoxic conditions. It is shown that
HIF-1a stabilization correlates with down-regulation of the tu-
mour suppressor von Hippel-Lindau protein (pVHL) and is pos-
itively controlled by NADPH-oxidase-dependent production of
reactive oxygen species, indicating a speciﬁc O2-independent
post-transcriptional control of HIF in mobilized HSCs. This no-
vel ﬁnding is discussed in the context of the proposed role of HIF
as a mediator of progenitor cell recruitment to injured ischemic
tissues and/or in the control of the maintenance of the undiﬀeren-
tiated state.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Adaptation to the environmental oxygen availability is of
crucial importance in controlling cellular/tissular bioenergetic
homeostasis [1]. Hypoxia-inducible factor (HIF)-1 is a ubiqui-
tously expressed master transcription factor that activates at
least 70 genes in response to hypoxic conditions [2,3], whichAbbreviations: BM, bone marrow; CsA, cyclosporin A; DCF, dichlo-
roﬂuorescein; DFX, desferrioxamine; DPI, diphenylene iodonium;
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erythropoietin; G-CSF, granulocyte colony stimulating factor; HIF,
hypoxia-inducible factor; HRE, hypoxia responsive element; HSC,
hematopoietic stem cell; LMN, lymphomononuclear; L-NNMA,
L-monomethyl-L-arginine; LSCM, laser scanning confocal micros-
copy; NOX, NADPH oxidase; PB, peripheral blood; PHD, prolyl
hydroxylase; pVHL, von Hippel-Lindau protein; RNS, reactive
nitrogen species; ROS, reactive oxygen species
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olism and angiogenesis [1–4]. HIF functions as a hetero-dimer
composed of two constitutively transcribed and translated sub-
units, HIF-1a and HIF-1b. While HIF-1b is an oxygen-inde-
pendent stable protein, HIF-1a is stabilized at low O2
concentrations (<3%) [1].
Although it is generally considered a stressful condition, hy-
poxia is normally present in tissular microenvironments. The
O2 concentration in bone marrow (BM) is much lower than
the average O2 level in the majority of tissues [5] and this is
particularly manifested near the bone endosteum, where the
hematopoietic niches are located [6]. Thus, resident hemato-
poietic stem cells (HSCs) can be envisaged as a specialized
cell-type, well adapted to an apparently hostile milieu where,
nevertheless, they undergo self-renewal [7]. Indeed, ex vivo
expansion of HSCs, without the loss of their regenerative po-
tency, is better achieved by culturing under low O2 tension
[8]. Intriguingly, in a recent cDNA microarray analysis, it
has been reported that among the 50–100 most highly up-reg-
ulated genes in human embryonic, hematopoietic (CD34+ and
CD133+), and mesenchymal stem cells, HIF-1a is the only up-
regulated transcription factor that they have in common [9].
Following appropriate stimuli, HSCs are mobilizable from
the BM and constitute a circulating reservoir that can repopu-
late exhausted ‘‘niches’’. Recent studies have indicated that tis-
sues that have experienced an ischemic insult can recruit
circulating HSCs bringing them into play to stimulate in situ
neo-vasculogenesis [10]. In both cases, the homing to BM or
extra-BM tissues leads HSCs to cope with a hypoxic environ-
ment.
The present study shows for the ﬁrst time that primary hu-
man granulocyte colony stimulating factor (G-CSF)-mobilized
HSCs express, under normoxic conditions, high levels of stable
HIF-1a and that the protein stabilization is positively con-
trolled by NADPH-oxidase-produced reactive oxygen species
and by limiting expression of the von Hippel-Lindau protein
(pVHL), suggesting in HSCs a more complex regulation of
HIF not exclusively related to the condition of O2 limitation
[11].2. Materials and methods
2.1. Cell samples
Peripheral blood (PB)-HSCs were obtained from healthy donors for
allogeneic transplantation after informed consent. Mobilization of
HSCs from BM by G-CSF-treatment was performed as in [12] andblished by Elsevier B.V. All rights reserved.
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The purity of the isolated cells was routinely >98% [12] and their via-
bility, determined by trypan blue exclusion, was typically between 80%
and 95%. Lymphomononuclear (LMN) cells were isolated from
peripheral heparinized venous blood by density-gradient sedimenta-
tion over Ficoll–Paque. EA.hy926, a hybridoma cell line derived by
fusing primary human umbilical vein endothelial cells (HUVEC) with
the permanent human cell line A549 (lung carcinoma), was grown in
Dulbecco’s minimum essential medium (DMEM) containing 10%
FBS.2.2. Immuno-cytochemistry and laser scanning confocal microscopy
(LSCM) analysis
PB-HSC samples (3 · 106/ml) and LMN were cyto-centrifuged on
poly-lysine coated slides, ﬁxed, permeabilized, blocked [as in [14]]
and incubated with 1:50 diluted mouse mAb anti-human HIF-1a (San-
ta Cruz) overnight at 4 C. Staining of EA cells was carried out under
identical conditions directly on glass bottom dishes. After two washes
in PBS, the samples were incubated with 8 lg/ml of the ﬂuorescein iso-
thiocyanate (FITC)- or rhodamine-labelled goat anti-mouse IgG (San-
ta Cruz). In the double staining experiments, the cells were incubated
simultaneously with the mouse anti-HIF1a and 1:50 diluted rabbit
anti-human pVHL (Santa Cruz) overnight at 4 C, followed by 1 h
incubation of FITC-labelled goat anti-mouse IgG and tetramethyl-
rhodamine isothiocyanate (TRITC)-labelled goat anti-rabbit IgG
(Santa Cruz), added sequentially. Imaging of labelled cells was per-
formed by a Nikon TE 2000 microscope (images collected using a
60· objective 1.4 NA) coupled to a Radiance 2100 dual laser scanning
confocal microscopy system (Biorad). The ﬂuorescent signals emitted
by the FITC-conjugated secondary Ab (kex, 490 nm; kem, 525 nm)
and by TRITC-conjugated secondary Ab (kex, 543 nm; kem,
572 nm) were from confocal planes of 0.2 lm in thickness examined
along the z-axes, going from the top to the bottom of the cells. Acqui-
sition, storage and analysis of data were made using LaserSharp and
LaserPix software from Biorad and Image J.
2.3. Analysis of HIF-1a protein by immunoblotting
5 · 107 cells/ml were suspended in ice-cold lysis buﬀer (20 mM
HEPES, pH 7.2, 150 mM NaCl, 1 mM EGTA, 10% glycerol, 1% Tri-
ton X-100, 1.5 mM MgCl2, 2 mM sodium phosphate, and protease
inhibitor cocktail). Lysates were centrifuged at 12000 rpm for 15 min
at 4 C and 60 lg of the supernatants were suspended in Laemmli’s
buﬀer and run on a 10% SDS–PAGE followed by Western-blotting.
After the transferring procedure, the membrane was blocked with
10% FBS in TTBS (10 mM Tris–HCl, 150 mM NaCl, 0.1% tween 20
pH 8) for 1 h at 37 C and subsequently incubated with the 1:300 di-
luted mouse mAb anti-HIF-1a (Santa Cruz) or 1:10000 diluted mouse
anti-b-actin (Sigma) overnight at 4 C. The membrane was washed
three times with TTBS and incubated for 1 h at room temperature with
the diluted 1:3000 horseradish peroxidase-conjugated secondary anti-
body (Santa Cruz). Subsequently, the membrane was washed three
times with TTBS, analyzed by chemiluminescence (Amersham) and
visualized with the VersaDoc Imaging System (Bio-Rad) by Quantity
One software.2.4. Reverse transcription-polymerase chain reaction
Total cellular RNA (3 lg) isolated by Trizol reagent was reverse
transcribed to cDNA with speciﬁc antisense primers (50 pmol each)
following the SuperScript Reverse Transcriptase protocol. Samples
of 5 lL of RT reaction were PCR-ampliﬁed in a total volume of
50 ll with 50 pmol each of sense and antisense primers. The primer se-
quences were HIF1-a, forward (f)-5 0-CTCAAAGTCGGACAGCCT-
CA-3 0, reverse (r)-5 0-CCCTGCAGTAGGTTTCTGCT-30 (460 bp);
b-actin, f-5 0-ACCAACTGGGACGACATGGAG-3 0, r-5 0-CGTGAG-
GATCTTCATGAGGTACTC-3 0 (35 bp). The conditions were 35 cy-
cles of denaturation at 94 C (1 min), annealing at 60 C (1 min), and
extension at 72 C (2 min) followed by a further 10 min of extension.
Puriﬁed PCR products were sequenced (three times for each sample)
on an automatic ABI Prism 310 DNA sequencer.
For quantitative RT-PCR, prior to reverse transcription, RNA was
subjected to DNAse (Ambion) treatment to remove contaminating
genomic DNA. First strand cDNA synthesis was carried out using
300 ng of random hexamer primers by Superscript II (Invitrogen),
starting from 300 ng RNA. Real-time quantiﬁcation was performedwith 2.5 ll cDNA using iQ SYBR Green Supermix (BIO-RAD) in
25 ll reaction volumes on an iCycler iQ detection system (BIO-
RAD, Hercules, CA, USA) with 300 nM forward and reverse primer
(VHL: f-5 0-GAGTACGGCCCTGAAGAAGA-30, r-5 0-GCGATTG-
CAGAAGATGACCT-30; b-actin: 5 0-TGGACATCCGCAAA-
GACCTG-30, r-5 0-GCCGATCCACACGGAGTACTT-3 0) and the
following cycling steps: initial denaturation for 3 min at 94 C, fol-
lowed by 45 cycles with 15 s at 94 C, 30 s at 60 C and 10 s at 72 C
and 10 min terminal elongation at 72 C. Melting curve analysis and
agarose gel electrophoresis were performed to conﬁrm the speciﬁcity
of the ampliﬁcation products. The relative quantiﬁcation of transcript
abundance in HSCs and LMNs was determined using the DDCt meth-
od using b-actin as an internal standard. Two technical repeats per bio-
logical sample were analyzed. The eﬃciency of ampliﬁcation,
determined by serial dilutions of templates, was close to 100% for both
transcripts and the liner regression coeﬃcients were P 0.997.2.5. HIF-1 DNA-binding assay
HIF-1 binding to a hypoxia responsive element (HRE) was assessed
using the Trans-AM HIF transcription factor assay kit (Active) Motif
Europe). Twenty micrograms of protein from cell lysates were ana-
lyzed for HIF-1 binding to an oligonucleotide containing the HIF-1
binding site from the erythropoietin (EPO) gene, according to the
manufacturer’s instructions using enzyme-linked immunosorbent as-
say technology with absorbance reading.
2.6. Flow cytometry
To measure reactive oxygen species (ROS) production, 106 cells were
incubated with 10 lM 2 0,7 0-dichlorodihydroﬂuorescein-diacetate
(H2DCFDA) at 37 C, protected from light for 30 min, in the presence
of 20 lM cyclosporin A (CsA) [14]. After loading with dye, the cells
were washed, resuspended in PBS and analyzed by a Beckman Coulter
Epics XL-MCL ﬂow cytometer equipped with a 488 nm Argon laser
following the instrumental procedure (kem, 529 nm). The emitted ﬂuo-
rescent signal was acquired and analyzed with Expo 32 ADC software
and was relative to 10000 events for each sample.2.7. Statistical analysis
The two tailed Student’s t-test was applied to evaluate the signiﬁ-
cance of diﬀerences measured throughout the data-sets reported. Sig-
niﬁcant diﬀerences were considered when P < 0.05.3. Results
3.1. PB-HSCs express a stabilized form of HIF-1a under
normoxic conditions
In this study, the analysis was carried out on freshly isolated
HSC samples, deliberately avoiding any further manipulation
(i.e. culturing) to keep the cells as close as possible to their
physiological state. Two immuno-selection procedures were
employed based on the CD34 and CD133 markers, the latter
ensuing in a cell population enriched in more primitive HSCs
[15].
Fig. 1A shows the result of a LSCM–immuno-cytochemistry
inspection to detect the presence of HIF-1a. It can be noted
that either the CD133- and CD34-PB-HSCs displayed a clear
intracellular ﬂuorescence documenting the possible expression
of the HIF-1a protein. The ﬂuorescent signal appeared mainly
localized in the thin extra-nuclear cytoplasmic rim (80% of
the total intracellular signal) as shown by imaging analysis of
median confocal planes along the z-axis (Fig. 1B). Similar re-
sults were obtained for mobilized-HSCs from diﬀerent donors
(8–10 HSC-sample preparations) and conﬁrmed by using a dif-
ferent HIF-1a-epitope-speciﬁc mAb (data not shown).
This observation, somehow surprising because it revealed
the presence of a stabilized form of the HIF-1a protein under
normoxic conditions (i.e. room air partial oxygen pressure),
Fig. 1. PB-HSCs express stable HIF-1a protein under normoxic conditions. (A) and (B) LSCM analysis for immuno-cytochemistry detection of
HIF-1a.The secondary Ab was FITC-conjugated and, when used on cell samples without the primary mAb, did not result in any detectable staining
(not shown). In (A) the images are the result of superimposed confocal planes and are representative of at least four diﬀerent preparations for each
HSC sample. Bars: 10 lm. Enlargements of single cell imaging are also shown for either CD34+ and CD133+ HSC samples. In (B), analysis of a
single confocal plane for a median section along the z-axis is shown (representative of >30 single CD34+HSC analysis). The pixel density proﬁle is
given along a line crossing the cell section and as a surface plot of the whole image. (C) immunoblotting of HIF-1a from cell lysates. (D) ELISA test
of HIF-1 DNA-binding assay of cell extracts; average (±S.E.M.) of 3–4 diﬀerent experiments with the reported P-value referring to the blank
assessing the speciﬁcity of the assay system. See Section 2 for further experimental details.
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extract (Fig. 1C). Moreover, the binding of protein cell-lysate
to an HRE-containing oligonucleotide, where HIF-1a speciﬁ-
cally binds, was assayed and resulted in semi-quantitative ELI-
SA readings that were statistically diﬀerent from the blank
assessing the speciﬁcity of the assay system (Fig. 1D).
Double immuno-cytochemistry of PB-HSCs for HIF-1a and
CD34 showed that more than 95% of HSCs possessing stabi-
lized HIF-1a were also CD34 positive, with a slight positive
correlation between the two antigens (data not shown). This
result indicated that the observed normoxic stabilization of
HIF-1a was a feature shared among all the PB-HSCs and
not conﬁned to a cellular subset.
3.2. Normoxic stabilization of HIF-1a in PB-HSCs CD34+
occurs at the post-translational levels and is not further
aﬀected by conditions mimicking hypoxia
In Fig. 2, a survey aimed at better characterizing the features
of HIF-1a in PB-HSC/CD34+ is presented. Identical analysis
was carried out on isolated human LMN and cultured EA
cells. The former was taken as an example of terminally diﬀer-
entiated blood cells along the myeloid and lymphoid lineages,
whereas the latter was chosen because it is widely utilized to
study the regulation of HIF-1a. Fig. 2A shows that, unlike
PB-HSCs, immunoblotting for HIF-1a resulted in an undetect-
able amount of the protein, for both LMN and EA cells,
whereas the mRNA transcription levels were comparable in
all the three cell samples assayed. The absence of the HIF-1a
protein in normoxic LMN and EA cells was also conﬁrmed
by immuno-chemical LSCM analysis (Fig. 2B). Furthermore,the observation of any signiﬁcant binding to HRE from
LMN and EA cell extracts corroborated the absence of evi-
dence in them for HIF-1a normoxic stabilization (Fig. 2C).
Fig. 2B, C shows, in addition, that treatment of LMN and
EA cell samples with desferrioxamine (DFX), a condition
mimicking hypoxia [16], induced stabilization of HIF-1a in
LMN and EA, but did not result in any further signiﬁcant ef-
fect on PB-HSCs when assayed by either immuno-cytochemis-
try or blotting (Fig. 2B). Moreover, the DNA-binding assay
conﬁrmed the DFX-induction of functional HIF-1 in LMN
and EA cells (Fig. 2C). Treatment of HSC, LMN and EA cells
with DFX did not cause any appreciable change in the HIF-1a
transcript level (tested by RT-PCR, data not shown). These
observations showed that our detection system was fully
appropriate and that HSCs expressed constitutively HIF-1a
under normoxia at a level comparable with that exhibited by
other cell-types under hypoxia-like conditions. Therefore the
presence of HIF-1a in mobilized normoxic HSCs was likely
due to post-translational stabilization rather than to enhanced
transcription.
3.3. Expression levels of HIF-1a and pVHL are inversely
correlated in CD34+ PB-HSCs
As rapid proteasome degradation of HIF-1a under norm-
oxic conditions is known to be driven by the intervention of
the tumour suppressor pVHL [17], we next investigated its
expression level by immuno-cytochemistry. Fig. 3A shows a
representative LSCM analysis of PB-HSC/CD34+ sample co-
stained for immuno-ﬂuorescence detection of both HIF-1a
and pVHL. A heterogeneous population of cellular subsets is
Fig. 2. Conditions mimicking hypoxia do not result in extra-stabilization of HIF-1a in PB-HSCs. (A) immunoblotting and mRNA expression of
HIF-1a in cell lysates from PB-CD34+HSCs, lymphomonocytes (LMN) and an endothelial-derived cell line (EA). (B) Laser scanning confocal
analysis for immuno-cytochemistry detection of HIF-1a in PB-HSCsCD34+, LMN and EA under normoxic conditions and following 12 h treatment
with 10 mM desferrioxamine (DFX). Representative experiments out of four are shown. Immuno-cytochemistry, as in Fig. 1A. The quantitative
analysis of the normalized ﬂuorescence increase caused by DFX treatment (i.e. (F+DFX  FDFX)/F+DFX) is displayed as bars (±S.E.M.; n = 4 for
each condition) superimposed on the LSMC images along with statistical evaluation. The eﬀect of DFX treatment on the HIF-1a protein level is also
shown as immunoblotting of the protein extract from the three cell-types (bottom part of the panel; representative of three experiments). (C) Eﬀect of
DFX treatment on the HIF-1 DNA-binding assay; average (±S.E.M.) of 3–4 diﬀerent experiments. NS: not signiﬁcant. See Section 2 for further
experimental details.
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and scant levels of pVHL, whereas others had high levels of
pVHL and practically no evidence of HIF-1a; besides these
two opposites, cells expressing intermediate levels of the two
proteins were detectable. A semi-quantitative analysis on sin-
gle cells of the subsets’ distribution revealed that more than
50% of the HSCs had a high level of stabilized HIF-1a and a
hardly perceptible amount of pVHL. The transcription level
of pVHL was tested by quantitative RT-PCR in diﬀerent
HSC samples and compared with that of the terminally diﬀer-
entiated LMN (Fig. 3B). It is shown that on an average basis,
HSCs displayed a signiﬁcantly lower level of pVHL transcript
(42% of LMN). Taken together, these results showed that
complete or partial stabililization of HIF-1a under normoxic
conditions in the largest set of the PB-HSCs was due to a
defective expression of pVHL.
3.4. HIF stability is controlled by NADPH-oxidase-dependent
ROS production
Stabilization of HIF-1a under normoxia has been reported
to be controlled by reactive oxygen and nitrogen species
(ROS, RNS) [18,19]. The analysis, the results of which are re-
ported in Fig. 4, was carried out to address this speciﬁc point.
Fig. 4A shows that when assayed by ﬂow-cytometry using the
ROS sensitive DCF probe, PB-HSCs revealed a constitutive
ROS production that was prevented by diphenylene iodinium
(DPI), an inhibitor of FAD-containing oxidases [20]. An even
stronger reduction of ROS production was attained upon
treatment of the cell sample with DFX. In this case, the chelat-
ing eﬀect of DFX is likely to abrogate the free iron-dependent
ROS formation by the Fenton-like reaction. On the other
hand, the generic NOS inhibitor, L-monomethyl-L-arginine(L-NNMA), did not cause any eﬀect on the ROS-producing
activity of the pre-treated cell sample. Fig. 4B,C shows that
treatment of HSC with DPI resulted in a 50% inhibition of
the binding capacity of HIF-1a to its target DNA sequence
and in an even more pronounced disappearance/degradation
of the protein when assayed by LSCM–immuno-cytochemis-
try. Conversely, L-NAME and DFX did not produce any ef-
fect, either on the DNA-binding activity or on the
stabilization of HIF-1a. As the eﬀect of DPI was evident fol-
lowing incubations as short as 2 h, this result suggested a po-
sitive control by ROS on the stabilization of HIF-1a at the
post-translational rather than transcriptional level. This con-
clusion was veriﬁed and validated by immunoblotting analysis
(Fig. 4D) showing a substantial decrease of the HIF-1a protein
level following DPI-treatment. The well-documented inhibi-
tory eﬀect of DFX on the prolyl-hydroxylases (PHDs) can ex-
plain its failure in destabilizing HIF-1a, notwithstanding the
observed large abrogation of ROS. This strongly indicates that
the HIF-1a-stabilization-eﬀect of ROS is mediated by their ac-
tion on the catalytic eﬃciency of PHDs. Fig. 4E shows that the
eﬀect of DPI was mimicked by apocynin (a more speciﬁc inhib-
itor of NADPH oxidase) but not by treatment of HSC with
rotenone plus antimycin A. The latter, when used together, in-
hibit ROS-generation by the mitochondrial respiratory chain,
whose involvement in the stabilization of HIF-1a could there-
fore be ruled out.4. Discussion
Stabilization of HIF-1a is controlled by two well-deﬁned
linked mechanisms: hydroxylation of speciﬁc residues and pro-
Fig. 3. Expression levels of HIF-1a and pVHL are inversely correlated in PB-HSCs CD34+. (A) LSCM analysis of PB-CD34+HSCs for double
immuno-cytochemistry detection of HIF-1a and pVHL. HIF-1a was green ﬂuorescent labelled with FITC-conjugated Ab, pVHL was red ﬂuorescent
labelled with a TRITC-conjugated secondary Ab; (a–c) are enlarged images of selected cells representative of subsets. A representative experiment
out of three is shown. Bars: 10 lm. Lower panel: quantitative correlation between the ﬂuorescence intensity of FITC- and TRITC-conjugated
secondary Abs bound to primary anti-HIF-1a and anti-pVHL, respectively. The values shown are averages (±S.D.) of clustered single cell image
analyses comprising around 100 randomly selected diﬀerent cells. The indicated percentage represents the calculated subset of cell distribution. (B)
Comparative quantitative RT-PCR assay for the pVHL mRNA in HSC and LMN. Upper panel: ampliﬁcation plot representative of four assays
performed with diﬀerent HSC and LMN samples. The inset shows the statistical analysis for the DCt values of VHL vs b-actin amplicons for either
cell-type. Lower panel: relative amount of the VHL transcripts in HSCs and LMNs estimated by the DDCt method with respect to the housekeeping
b-actin gene transcript and normalized to the LMN value (average ±S.E.M. from four diﬀerent HSC samples. See Section 2 for further experimental
details.
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that mediate post-translational modiﬁcation of two conserved
proline residues in HIF-1a at positions 402 and 564 [21]. Un-
der normoxia, HIF-1a is prolyl-hydroxylated and as such, pro-
vides recognition sites for the binding of the pVHL. This
tumour suppressor, once bound to HIF-1a, recruits the E3
ubiquitin ligase complex and promotes its extensive ubiquiti-
nation and targeting to proteasome degradation [17,22]. The
aﬃnity of PHD for O2 is such that when its concentration falls
below 3%, it becomes limiting and therefore, the pVHL-medi-
ated degradation is strongly reduced. Consequently, HIF accu-
mulates and can translocate into the nucleus where it forms,
with its partner HIF-1b, a hetero-dimer able to bind HREs
on promoters or enhancer regions. Unlike most nucleus-im-
ported proteins, which require the common importins a or b,
nuclear translocation of HIF-1a is mediated by diﬀerent
importin isoforms, which bind peculiar nuclear localization se-
quences (NLS) of HIF-1a [23]. A limiting expression of these
speciﬁc nuclear translocation factors in HSCs might explain
the predominant extracellular localization of HIF-1a under
normoxia reported herein. Of note, full gene-transactivationby HIF also depends on the recruitment of coactivators (like
P300/CBP, SRC-1, Ref-1), which is negatively regulated by
hydroxylation of aspargine 803, the target of another speciﬁc
prolyl-hydroxylase (FIH, factor inhibiting HIF-1a) [24].
Therefore, stabilization of HIF-1a can be achieved by either
limiting the availability of pVHL or desensitizing PHD to O2-
activation. These two features are both matched in the evi-
dence provided in the present study. Indeed, immuno-cyto-
chemistry analysis with an antibody recognizing pVHL failed
to detect the protein in all but a limited subset of CD34+
PB-HSCs and, moreover, the cellular distribution of the
HIF-1a was inversely related to the expression of pVHL. This
is evocative of what has been observed in a number of cancer-
ous cells where the absence of an active pVHL is associated
with enhanced HIF-related vasculogenesis activity [25]. To
our knowledge, the sole report of a physiological down-regula-
tion of pVHL concerns human cytotrophoblast stem cells dur-
ing uterine invasion under normoxia [26]. Unlike the shortage
of information about the O2-regulation of pVHL, the desensi-
tization under normoxia of PHDs is amply documented. Reac-
tive oxygen and nitrogen species (ROS, RNS) have been
Fig. 4. HIF stability is controlled in PB-HSCs by NADPH-oxidase-dependent ROS production. Eﬀect of DPI, DFX and L-NNMA on: (A)
intracellular ROS production, assayed by ﬂow cytometry with dichloroﬂuorescein (DCF); (B) HIF-1 DNA-binding assay; (C) immuno-
cytochemistry detection of HIF-1a by confocal microscopy. HSCs were incubated with 20 lM DPI or 10 mM DFX or 1 mM L-NNMA for 2 h at
37 C. (D) Eﬀect of DPI-treatment on HIF-1a protein assayed by immunoblotting. The fold increase of the HIF-1a protein following DPI-treatment
and assayed by densitometry of the HIF-1a band normalized to b-actin and to the untreated HSC sample (Ctrl) is shown (representative of three
experiments yielding similar results). (E) Eﬀect of 100 lM apocynin or 2 lM rotenone + 1lM Antimycin A on HIF-1a LSCM–immuno-
cytochemistry (incubation conditions for the inhibitors as for A–D). In (C) and (D), the secondary Ab was conjugated with FITC and rhodamine,
respectively, and the quantitative analysis of the ﬂuorescence expressed as percentage of that in untreated HSCs (Ctrl) is displayed as bars (±S.E.M.;
n = 4 for each condition) along with statistical evaluation. White bars, 10 lm.
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the mechanism of inhibition has not yet been fully elucidated,
two feasible modalities of action have been proposed. ROS
and RNS can directly ligate to the active ferrous iron center
of PHDs (altering its redox properties) and/or may promote
phosphorylation-dependent stabilization of HIF-1a [27]. In
these latter cases, ROS and RNS would function as second
messengers, possibly due to their well-documented inhibitory
action on protein phosphatase activity [28].
In a previous work, we showed that HSCs are endowed with
a constitutively active NADPH oxidase, which generates low-
regiment ROS [14]. Here, we show that inhibition of ROS pro-
duction by DPI-treatment causes a marked destabilization of
HIF-1a. RNS, on the other hand, do not seem to be involved
in HIF stabilization, as treatment of PB-HSC with an inhibitor
of the NOS-synthase(s) was ineﬀective.
A very recent report has shown that glycogen synthase ki-
nase 3 (GSK3) phosphorylates HIF-1a in the oxygen-depen-
dent domain (ODD) leading to its proteasome degradation
via a VHL-independent mechanism [29]. Activation of the pro-
tein kinase B (PKB) pathway, which phosphorylates and inac-
tivates GSK3, promotes HIF-1a stabilization. Notably, ROS
are well-known activators of the PKB pathway, and thus, ele-
vation of intracellular ROS might mediate stabilization ofHIF-1a via this newly discovered additional mechanism, be-
sides that controlling the PHD/VHL system. If this alternative
mechanism is operative in HSCs, it might explain our observa-
tion that reduction of ROS by DPI-treatment causes substan-
tial degradation of HIF-1a in all of the cell populations,
including the VHL-deﬁcient subset.
The reported aﬃnity for O2 of NADPH oxidase (NOX)
(Km  10 lM) [30] enables ROS production eﬃciency to be
sensitive to the physiological range of O2 concentration expe-
rienced by HSCs when passing from BM (5–15 lM O2) to
PB (40–50 lM O2) [5]. However, the absence of a stabilized
HIF-1a protein in isolated BM-resident HSCs (also expressing
NOX isoforms like in PB-HSCs [Piccoli et al., unpublished re-
sults]) when assayed under normoxic conditions (data not
shown), strongly suggests that factors other than the level of
O2 are involved. It might well be that mobilization of BM-
residing HSCs by G-CSF-treatment promotes events linked
to stabilization of HIF. Of note, recent observations indicate
that G-CSF binding to its cognate receptor on myeloid cell-
types causes an increase of ROS production by at least two
modalities. One involves the Lyn-PI 3K-kinase-Akt cascade
[31], and the other, the ferritin-labile iron pool pathway [32].
Moreover, it has been reported that some of the gene products
controlled by HIF (like EPO) stimulate ROS production as
Fig. 5. Scheme showing the proposed mechanism for HIF-1a stabilization in mobilized HSCs under normoxic conditions. The initial event leading to
activation of NOX is proposed to be linked to the chemokine (G-CSF or SDF-1) signal transduction pathway. Consequent increase of ROS would
cause stabilization of HIF-1a under normoxic conditions, likely via inhibition of prolyl-hydroxylases (PHD). Nuclear translocation of HIF-1a
promoting the trans-activation of HRE-linked genes might support cell survival and, in addition, sustain via an autocrine mechanism a positive feed-
back loop for redox signalling. Moreover, binding of HIF-1a to Notch regulated genes would activate the expression of specialization-suppressing
genes favouring maintenance of the uncommitted state. See Section 4 for further explanation.
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NOX-dependent ROS production, and activation of HIF
would turn in an autocrine positive feed-back mechanism of
maintenance under normoxia [34–36]. A working model illus-
trating the possible mechanism of HIF-1a stabilization under
normoxia in PB-HSCs is shown in Fig. 5; the obvious question
remaining to be answered concerns its physiological meaning.
Although speculative, it is tempting to make suggestions
based on the latest reports. A very recent study carried out
in HIF-1a-knock out mice showed that HIF-1a deﬁciency
caused hematopoietic defects downstream of multipotential
myeloid progenitors, which were more pronounced in the com-
mitted erythroid progenitors [37]. Moreover, the ﬁnding that
the homozygosis condition of the pVHL R200W mutation
causes Chuvash polycytemia [38] supports the critical role of
HIF in promoting survival, proliferation and diﬀerentiation
of hematopoietic progenitors. One further possibility is that
HIF stabilization may represent a sort of pre-conditioning,
conferring an advantage for homing of BM-mobilized HSCs
to hypoxic tissues preserving at the same time the undiﬀerenti-
ation state. Hypoxic tissues, like peri-ischemic areas in the
heart, have been shown to promote a larger HSC mobilization
by release of stromal-derived factor (SDF-1), which acts at the
level of bone marrow, recruiting in the circulating blood undif-
ferentiated HSCs [10,39]. Following a chemotactic gradient,
HSCs can reach the hypoxic tissue and provide therein a
source of endothelial precursors that could help in the re-vas-
cularization process, as recently suggested by a study showing
that endothelial cells are an intrinsic component of adult mye-
loid lineage diﬀerentiation [40]. Given the inter-changeable fea-
tures shared by chemokines and growth factors [41], it is
possible that G-CSF conditioning might mimic the physiolog-ical BM-mobilization of HSCs [42] under emergency condi-
tions.
Very recent observations have provided a molecular mecha-
nism for the inhibition of hypoxia on terminal diﬀerentiation
of stem cells. It has been reported that HIF-1a binds to the
cleaved intracellular domain of Notch and is recruited to the
promoter regions of Notch-responsive genes [43]. Activation
of Notch signalling makes available repressors that down-reg-
ulate specialization genes. Consistent with this observation,
hypoxia maintains the expression of pref-1, a key stem/pre-
cursor cell gene that negatively regulates adipogenic diﬀerenti-
ation by a mechanism in which HIF-1a has been demonstrated
to be involved [44].
In summary, the data here presented show, for the ﬁrst time,
that human PB-HSCs CD133+/CD34+ are endowed with a
system enabling the stabilization of HIF-1a under normoxic
conditions. Our results indicate that two mechanisms would
contribute to HIF stabilization: one is based on the constitu-
tive NOX-dependent ROS generation which likely inhibits
PHDs, the other on the down-regulation in the expression of
pVHL in a subset of PB-HSCs. Chemokine-dependent mobili-
zation from the bone marrow of HSCs is suggested to be the
event triggering activation of HIF, which then is self-main-
tained by a redox-dependent positive feed-back regulation.
In view of the recently recognized role played by HIF in con-
trolling maintenance of the undiﬀerentiated state in stem/pro-
genitor cells, our ﬁnding might have possible applications in
regenerative medicine.Acknowledgements: This work was supported by the University of
Foggia, Funds for Research ‘‘Quota progetti 2004/05’’. The authors
thank Dr. R. Ria for kindly providing the EA cells.
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